| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.49B | 1.42B | 1.30B | 1.20B | 1.19B |
| Gross Profit | 317.96M | 398.28M | 330.81M | 278.88M | 191.81M |
| EBITDA | 214.11M | 215.17M | 141.18M | 116.67M | 124.34M |
| Net Income | 129.07M | 94.80M | -6.78M | 9.21M | -15.79M |
Balance Sheet | |||||
| Total Assets | 2.31B | 2.13B | 1.94B | 1.81B | 1.82B |
| Cash, Cash Equivalents and Short-Term Investments | 293.63M | 247.50M | 180.26M | 163.68M | 263.77M |
| Total Debt | 913.04M | 957.09M | 838.32M | 753.64M | 720.98M |
| Total Liabilities | 1.25B | 1.23B | 1.11B | 1.03B | 988.91M |
| Stockholders Equity | 1.06B | 891.71M | 823.69M | 787.31M | 835.82M |
Cash Flow | |||||
| Free Cash Flow | 56.15M | -77.97M | -49.47M | -63.70M | 92.79M |
| Operating Cash Flow | 198.17M | 177.42M | 32.04M | -14.13M | 123.85M |
| Investing Cash Flow | -87.33M | -245.95M | -47.32M | -44.14M | -17.37M |
| Financing Cash Flow | -65.81M | 141.10M | 22.04M | -19.91M | -63.48M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | $29.52B | 19.37 | 29.62% | 0.44% | 11.73% | 45.70% | |
77 Outperform | $3.60B | 6.88 | 39.31% | ― | 8.71% | 72.09% | |
73 Outperform | $1.45B | 8.25 | 12.87% | ― | 4.78% | 156.83% | |
67 Neutral | $1.41B | 30.17 | 1.97% | ― | -1.95% | 530.91% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
58 Neutral | $7.02B | 40.10 | 2.26% | 3.24% | -1.43% | -63.13% |